Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Esophageal Neoplasms 3Prostatic Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thymoma 1Stomach Neoplasms 1Sarcoma 1Phyllodes Tumor 1Lymphatic Metastasis 1Liver Neoplasms 1Laryngeal Neoplasms 1Laryngeal Diseases 1High-Risk Cancer 1Endometrial Neoplasms 1Carcinoma, Hepatocellular 1Breast Cancer Radiotherapy 1

Interventions

Sorafenib 61Bevacizumab 42Oxaliplatin 24Doxorubicin 22Radiosurgery 20Gemcitabine 20Fluorouracil 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17Capecitabine 17lenvatinib 16Cisplatin 16atezolizumab 13Leucovorin 13Radiotherapy 11tremelimumab 10Cyclophosphamide 10Carboplatin 10Irinotecan 9Ipilimumab 9Drug Therapy 9Everolimus 8Cryosurgery 8toripalimab 7fludarabine 7Sunitinib 7Chemotherapy, Adjuvant 7Melphalan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Liver Neoplasms × Radiotherapy, Adjuvant × Clear all
NCT01456156 2017-07-05

Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma

ChineseAMS

Phase NA Completed
76 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡